Financhill
Back

Zentalis Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21

ZNTL
Zentalis Pharmaceuticals, Inc.

Last Price:
$1.41
Seasonality Move:
-21.46%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZNTL is experiencing slight selling pressure.

Zentalis Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.4 Sell
20-day SMA: 1.4 Buy
50-day SMA: 1.44 Sell
200-day SMA: 1.46 Sell
8-day EMA: 0.74 Buy
20-day EMA: 0.36 Buy
50-day EMA: 0.16 Buy
200-day EMA: 0.04 Buy

Zentalis Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 49.72 Sell
Chaikin Money Flow: -256757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.34 - 1.42) Buy
Bollinger Bands (100): (1.36 - 1.66) Sell

Zentalis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Zentalis Pharmaceuticals, Inc. Stock

Is Zentalis Pharmaceuticals, Inc. Stock a Buy?

ZNTL Technical Analysis vs Fundamental Analysis

Sell
21
Zentalis Pharmaceuticals, Inc. (ZNTL) is a Sell

Is Zentalis Pharmaceuticals, Inc. a Buy or a Sell?

Zentalis Pharmaceuticals, Inc. Stock Info

Market Cap:
101.2M
Price in USD:
1.40
Share Volume:
770.3K

Zentalis Pharmaceuticals, Inc. 52-Week Range

52-Week High:
3.33
52-Week Low:
1.01
Sell
21
Zentalis Pharmaceuticals, Inc. (ZNTL) is a Sell

Zentalis Pharmaceuticals, Inc. Share Price Forecast

Is Zentalis Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Zentalis Pharmaceuticals, Inc.

Is Zentalis Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.16 per share.

Technical Analysis of Zentalis Pharmaceuticals, Inc.

Should I short Zentalis Pharmaceuticals, Inc. stock?

* Zentalis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.